A carregar...
Immune checkpoint inhibitor therapy for pediatric cancers: A mini review of endocrine adverse events
In recent years, immune checkpoint inhibitor therapy has attracted a great deal of attention in the field of cancer treatment. In the clinical setting, antibodies targeting programmed cell death-1 (PD-1) and cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) have been successfully used to treat ad...
Na minha lista:
| Publicado no: | Clin Pediatr Endocrinol |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
The Japanese Society for Pediatric Endocrinology
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6646237/ https://ncbi.nlm.nih.gov/pubmed/31384097 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1297/cpe.28.59 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|